All news

Argus raises target for Cencora stock to USD 380.00

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

Argus has increased its price target for Cencora (COR) stock from USD 340.00 to USD 380.00. This follows Cencora's agreement to acquire American Oncology Network for USD 2.4 billion and an upward revision of its fiscal 2026 adjusted diluted earnings per share guidance. Cencora is set to release its fourth-quarter fiscal 2026 results on November 4, 2026.

Read original source

COR company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.